ABSTRACT Polymeric IgA (plgA) is transported by liver parenchymal cells (hepatocytes) from blood to bile via a receptor-mediated process. We have studied the intracellular pathway taken by a TEPC15 mouse myeioma plgA. When from 1 pg to 1 mg 12Sl-plgA was injected into the saphenous vein of a rat, 36% was transported as intact protein into the bile over a 3-h period. The concentration of transported 1251-plgA was maximal in bile 30-60 min after injection, and -80% of the total 12Sl-plgA ultimately transported had been secreted into bile by 90 min. A horseradish peroxidase-plgA conjugate (~251-plgA-HRP) was transported to a similar extent and with kinetics similar to that of unconjugated 1251-plgA and was therefore used to visualize the transport pathway. Peroxidase cytochemistry of livers fixed in situ 2.5 to 10 min after ~2Sl-plgA-HRP injection demonstrated a progressive redistribution of labeled structures from the sinusoidal area to intermediate and bile canalicular regions of the hepatocyte cytoplasm. Although conjugate-containing structures began accumulating in the bile canalicular region at these early times, no conjugate was present in bile until 20 min. From 7.5 to 45 min after injection ~30% of the labeled structures were in regions that contained Golgi complexes and lysosomes; however, we found no evidence that either organelle contained ~2Sl-plgA-HRP. At least 85% of all positive structures in the hepatocyte were vesicles of 110-160-nm median diameters, with the remaining structures accounted for by tubules and multivesicular bodies. Vesicles in the bile canalicular region tended to be larger than those in the sinusoidal region. Serial sectioning showed that the 1251-plgA-HRP-containing structures were relatively simple (predominantly vesicular) and that extensive interconnections did not exist between structures in the sinusoidal and bile canalicular regions.
Receptor-mediated endocytosis is an important cellular process by which macromolecules enter cells. Liver parenchymal cells (hepatocytes) internalize a wide variety of molecules from the circulation via this mechanism; however, once endocytosed, the ligands exhibit diverse intracellular fates. Asialoglycoproteins (41) and epidermal growth factor (6) are taken up by rat hepatocytes and degraded in lysosomes, whereas polymeric leA (picA) 1 is transported from blood to Abbreviations used in this paper: HRP, horseradish peroxidase; PC25-BSA-Sepharose 4B, Sepharose 4B to which 2.9 mg phosphorylcholine25-bovine serum albumin per ml is attached; plgA, polymeric t2SlgA; ~25I-plgA-HRP, conjugate between plgA and HRP; SC, secretory component; TBS, Tris-HCl-buffered saline.
bile without degradation (24, 27, 30, 40) . The fates of the surface receptors can also vary in hepatocytes. The asialoglycoprotein receptor is reutilized for further rounds of ligand internalization (33, 38) , whereas the receptor for epidermal growth factor is degraded when cells are exposed to the hormone (6a). Secretory component (SC), the receptor for plgA, is transported across the cell and secreted with its ligand as a complex (7, 16, 17) .
Most of the pleA that is transported from blood to bile in the liver is synthesized by plasma cells found in the lamina propria of the intestinal mucosa and enters the bloodstream at the thoracic duct (15) . Circulating pleA is then bound at the sinusoidal front of hepatocytes and transported across the THE JOURNAL OF CELL BIOLOGY -VOLUME 101 DECEMBER 1985 2113-2123 2113 cell, processes mediated by SC, a pig, A-specific receptor synthesized in the hepatocyte (7, 17, 23, 31, (34) (35) (36) . During transport of the SC-pIgA complex across epithelial cells, the membrane-anchoring domain (20-36 kD) of the transmembrane receptor is cleaved (20, 32, 34) . Morphological and biochemical studies have suggested that pIgA is transported across the hepatocyte within small vesicles (21, 27, 37 ). Another view has been put forward by Geuze et al., who reported that pIgA and asialofetuin, a ligand for the asialoglycoprotein receptor, are segregated from each other in a tubule network (compartment of uncoupling of receptors and ligand) that extends from the sinusoidal cell periphery to the trans-Golgi area (bile canalicular region) of the hepatocyte (9) . They suggest that pIgA is sorted from asialoglycoproteins in this tubule network, with packaging of pIgA in vesicles for subsequent transport to the bile front. Thus, there is not yet agreement as to the pathway by which plgA traverses the hepatocyte.
In this study we have extended the findings of Takahashi et ai. (37) and Geuze et al. (9) . A horseradish peroxidase (HRP) conjugate of mouse mI-pIgA (125I-pIgA-HRP) and electron microscopic cytochemistry were used to identify and quantitate the intracellular structures involved in the uptake, accumulation, and release of plgA by rat hepatocytes. We have found that 85% of the total 12SI-plgA-HRP-containing structures at all times analyzed were discrete vesicles, with tubules and multivesicular bodies composing the remaining 15 %. In addition, we have found that the vesicles in the bile canalicular region of the hepatocyte tended to be larger than those in the sinusoidal region, which suggests that the ligand is repackaged during transport. Finally, serial sections showed that in most cases vesicles and tubules were not interconnected. Preliminary portions of this work have been presented elsewhere ( 11 ).
MATERIALS AND METHODS

Materials
Phosphorylcholine chloride (calcium salt) and o-dianisidine dihydrochloride were from Sigma Chemical Co. (St. Louis, MO); complete and incomplete Freund's adjuvant were from Difco Laboratories Inc. (Detroit, MI); and female New Zealand white rabbits ( 10-12 lb) were supplied by Bunnyville (Littletown, PA). The phosphorylcholinexs-bovine serum albumin-Sepharose 4B (PC2rBSA-Sepharose 4B) was a generous gift of Dr. Y. C. Lee, Johns Hopkins University. Rabbit anti-rat SC antibody was produced using soluble SC from rat bile as an immunogen. Other reagents were obtained from the same sources given in recent publications from this laboratory (l, 6, 14, 29, 41, 42) or were of the highest purity available commercially and were used without further purification.
Preparation of plgA
The plasmacytoma cell line, TEPC15, produces an IgA that binds phosphorylcholine (26) and was kindly supplied by Dr. Potter (National Cancer Institute, National Institutes of Health) and Litton Bionefics (Kensington, MD). The cells were grown in the ascites form in pristane-primed BALB/c mice where IgA concentrations reached 4-6 mg/ml ascites. Cells and clotted blood were removed from the ascites by centrifugation (1,300 g, 15 min), and sodium azide was added to a final concentration of 3 mM. The ascites could be stored in this state at 4"C for at least 8 too.
The entire purification of plgA was done at 4"C. Ascites fluid (25 ml) was clarified by centrifugation (100,000 g, 60 rain) and then applied to a PC~-BSASepharose 4B affinity column (2 x 5 cm) that had been equilibrated in 0.15 M NaCI, 20 mM Tris-HCl, pH 7.4 (TBS). The column was washed with 10 column vol TBS until absorbance at 280 nm reached 0.04. 5 mM phosphorylcholine chloride in TBS was used to elute IgA in a peak that was 24 ml (1.5 column vol). Monomer and polymer forms oflgA were separated on a Sephadex
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THE JOURNAL Of CELL BIOLOGY • VOLUME 101, 1985 G-200 column (2.5 x 100 cm), equilibrated, and run in TBS. The fractions were analyzed by native polyacrylamide gel electrophoresis (PAGE), and only those fractions that contained plgA were pooled. The polymer content of the affinity column IgA pool ranged between 50 and 80% and of the final plgA after gel filtration between 98 and 100% by densitometric analysis of polyacrylamide gels. The final preparation was >98% IgA as judged by SDS PAGE (in 7.5 and 7-12% polyacrylamide gels) using Coomassie Blue staining and autoradiography of gels of t25I-plgA. Aliquots were frozen in liquid nitrogen and stored at -70"C.
Preparation and Characterization of plgA-HRP
plgA-HRP was prepared according to the procedure of Wall et al. with two modifications (41) . Oxidized HRP (1.33 rag) was added to 10 mg n~l-plgA (4.31 x 104 cpm/zg) for the coupling reaction, and sodium cyanoborohydride (34 mM) was substituted for sodium borohydride in the reduction step. Unconjugated HRP was removed from conjugated and unconjugated nSI-plgA on a PC2rBSA-Sepharose 4B affinity column (0.8 x 3 cm). The pooled elution peak, which contained both conjugate and free 12~l-plgA, was designated ~251-plgA-HRP conjugate. The amount of HRP protein in the final conjugate was determined from activity measurements, by comparison with an HRP standard that had been oxidized but not coupled to plgA. The final conjugate (three preparations) ranged from -4 to 200 zg HRP bound per 100 mg ~2SI-plgA, or 0.005 to 0.4 mol HRP/mol plgA (using Mr 700,000 for plgA). The 1251-plgA-HRP was further characterized by native PAGE and by comparison of its transport kinetics to that of unconjugated ~25I-plgA. t251-plgA-HRP was stored at -70*C.
In Vivo Clearance and Transport into Bile
ASSESSMENT OF 1251-plgA AND 1251-pIgA-HRP CLEARANCE FROM THE BLOOD AND TRANSPORT INTO BILE; The in vivo clearance and transport of t2Sl-plgA (1-I,000 t~g) and 12SI-plgA-HRP (300-800 #g) were determined as previously described for other liver-specific ligands (12) . The bile duct was cannulated with PE-10 Intramedic polyethylene tubing (Clay-Adams, Parsippany, NJ), and bile was collected over 10-min intervals from 0-30 min, 15-rain intervals from 30-60 min, and 30-min intervals thereafter.
CHARACTERIZATION OF 1251-plgA AND 12SI-plgA-HRP IN SERUM AND BILE SAMPLES BY AFFINITY CHROMATOGRAPHY: Serum and bile samples containing ml-plgA or t:51-plgA-HRP were diluted 1/10 in TBS, 0.05% (wt/vol) BSA and applied to a small PC2s-BSA-scpharose 4B column (0.8 x 3.0 cm), and 0.3-ml fractions were collected as described above (Preparation of plgA) with 0.05% (wt/vol) BSA in all column buffers.
Native PAGE
plgA samples were analyzed on 5-7% polyacrylamide slab gels according to the method of Maizel (19) as previously described (13) , but SDS was omitted from both resolving and slicking gels to prevent dissociation of light chains from the polymers. Samples were applied in 50 mM Tris-HC1, pH 8.9, 0.4 M sucrose, 0.002% (wt/vol) bromphenol blue. Since separation of the plgA polymers required prolonged electrophoresls, horse spleen ferritin (300 zg) was used as a standard, and the gel was stopped when the fastest running band (M, of apoferritin, 460,000) had migrated two-thirds the length of the gel. Gels were stained with Coomassie Blue, destained (19) , and dried, if ~251-pIgA was being analyzed, the dried gel was exposed to x-ray film (Kodak XAR-5). Bands on the developed film were quantilited using a GS300 Transmittance/Reflectance Densitometer (Hoefer Scientific Instruments, San Francisco, CA) interfaced with a Hewlett-Packard 3390A integrator (Avondale, PA).
Characterization of 12Sl-plgA-HRP on Nitrocellulose Transfers
The 12SI-pIgA-HRP polymers separated by native PAGE were electrophoretically transferred to nitrocellulose by the method of Towbin et at. (39) . The nitrocellulose transfer was quenched with 2% gelatin, 10 mM sodium phosphate, pH 7.4, 0.14 M NaCI, 3 mM KCI before incubation in 1.4 mM 3,Ydiaminobenzidine, 0.03% (wt/vol) H202, 50 mM Tris-HCl, pH 7.6. Bands of peroxidase reaction product appeared in ~30 s. After two 1-min washes in deionized water, the peroxidase reaction was stopped by the addition of 3% (wt/vol) trichloroacetic acid. After 15 min, the transfer was rinsed in deionized water, blotted dry, and exposed to x-ray film at -70°C with intensifying screen, and the film was developed.
Morphology
LOCALIZATION OF t251-plgA-HRP IN SITU: t251-plgA-HRP(0.5-1.0 mg plgA) and mannan (I.0 rag) were mixed and injected into the sapbenous vein of fasted Sprague-Dawley rats under phenobarbital anesthesia, and at various times the livers were perfused in situ through the hepatic portal vein, first with 0.9% (wt/vol) NaC1 for 10-20 s and then with 2% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4, for 5 rain (12) .
HRP activity in the fixed liver was detected as described previously (41) . After the diaminobenzidine reaction, sections were rinsed in Tris buffer and treated with 1% OsO,, 1% K4Fe(CN)e-3H20, 0.1 M sodium cacodylate, pH 7.4 (filtered through a Millipore type GS filter, 0.22 ~m, Millipore Corp., New Bedford, MA) for 45 rain at 4"C (3). After they were rinsed in deionized water at 23"C for 30 s, the sections were dehydrated and embedded in Epon for electron microscopy.
QUANTITATION OF 1251-plgA-HRP-CONTAINING STRUCTURES IN HEPATOCYTES: The numbers and distributions of intracellular structures containing ~251-plgA-HRP were determined on thin sections from livers fixed at various times after in vivo injection of ligand. Structures were counted with the aid of a magnifying glass from random micrographs printed at a final magnification of 8,000. The hepatocyte cytoplasm was divided into three regions (sinusoidal, bile canalicular, and intermediate) and the number of ]251-plgA-HRP-containing structures quantified in each of the regions. A structure was considered to be sinusoidal when found within 1.6 t~m of the base of sinusoidal plasma membrane microvilli, bile canalicular when found within 2.2 um of the base of bile canalicular plasma membrane, and intermediate if a structure did not fall into either of the other two regions.
Golgi-lysosome regions of hepatocytes were defined morphologically as areas in which Golgi stacks and lysosomes could be identified, and in most eases rough endoplasmic reticulum and mitochondria were absent. About 50% of such areas were near bile canaliculi (within -2.2 ~m), and the remainder were in intermediate regions as defined above. 1251-pIgA-HRP-containing vesicles, tubules, and multivesicular bodies were quantified in the Golgi-lysosome regions of the hepatocyte. Vesicles and tubules tended to have a homogeneous intensity of internal HRP reaction product, whereas multivesicular bodies were larger structures in most cases and contained distinguishable internal vesicles or other inclusions. The diameters of ~25I-pIgA-HRP-positive vesicles in the sinusoidal, bile canalicular, and intermediate regions were measured on micrographs of cells from livers fixed at 7.5, 15, and 30 rain after injection of the conjugate.
ANALYSIS OF 1251-plgA-HRP-CONTAINING STRUCTURES USING SERIAL SECTIONS: The size, shape, and possible interrelationships of conjugate-containing structures were examined on serial 70-nm sections of tissue from livers fixed 15 and 30 min after ~2~I-plgA-HRP injection. Section thickness was calculated as one-half the width of section folds measured on micrographs of known (and calibrated) magnification. 13 series of 6-14 sections each (average of 8/series) were examined.
Other Methods
ACID PRECIPITATION OF t2sl-plgA: Samples of bile, plasma and liver bomogenate were incubated at 4"C for 30 min in 10% (wt/vol) tricbloroacetic acid, 0.5% (wt/vol) phosphotungstic acid, 1 mM KI, and then sedimented (1,300 g, 15 min) at 4"C. The pellet was washed once with the trichloroacetic acid/phosphotungstic acid solution before the radioactivity associated with it was determined. The precipitated radioactivity was a measure of t2~l covalently attached to plgA.
RADIOIODINATION OF PROTEINS: The plgA was radioiodinated as described previously (14) to 3-5 x l09 cpm/mg, stored in aliquots at -70"C, and used within 6 wk after radioiodination. Protein A was radioiodinated by a chloramine-T procedure to a specific activity of 2-4 x 101° cpm/mg (29) .
RESULTS
Biochemical Characterization of
1251-plgA Transport
I251-plgA CLEARANCE AND TRANSPORT TO BILE"
The concentration of 125I-plgA in blood reached a maximum between 2.5 and 10 min after intravenous injection of the ligand and then decreased steadily out to 180 min (Fig. l) . Radioactivity was first detected in bile 20 min after ligand injection and reached its highest concentration there between 30 and 60 min (Fig. 1) . Routinely, by 3 h 30-40% of the injected radioactivity had been transported to bile, a value that was independent of the 125I-plgA levels administered, which ranged from 1 #g to 1 mg (inset, Fig. 1) .
In seven separate experiments, the distribution of radioactivity 180 min after injection was as follows (mean __+ SD): 36 _ 4% was transported to bile, 11 _ 3% was in liver, and 34 + 7% remained in the blood. An average of 81 _.+ 9% of the injected radiolabel could be accounted for in bile, blood, and liver, with the remaining 15-20% in the stomach, intestine, thyroid, spleen, kidney, lung, colon, and heart. 180 min after injection of t25I-plgA, <20% of the radioactivity in liver homogenate and >80% of the radioactivity in stomach and intestine contents were acid soluble. Therefore, -12% of the injected radioactivity was recovered in a degraded form (iodide or small peptides) from the stomach, intestine, and liver.
CHARACTERIZATION OF 1251-plgA TRANSPORTED
TO BILE: The nature of the radioactivity in the bile was investigated to ascertain that 125I-plgA was being transported intact across the hepatocyte. More than 90% of the radioactivity collected in bile samples up to 90 min was acid insoluble. Thereafter, the acid-insoluble radioactivity fell but was never less than 70% of the total up to 180 min.
Native PAGE followed by autoradiography was used to compare transported radioactivity with the injected 12SI-plgA (Fig. 2) . Three I25I-pIgA bands were present in the injected sample. We have designated the three I25I-bands as the dimer (band 3), tetramer (band 2), and hexamer (band l) forms of pIgA, based on their elution behavior from the Sephadex G-200 column used to purify pIgA. These assignments are consistent with data on pIgA from three other mouse plas- Fig. 1 were analyzed by native PAGE (see Materials and Methods). Bands 3, 2, and 1 represent the polymeric forms of plgA in our preparation which we believe to be dimer, tetramer, and hexamer, respectively. When this experiment was repeated, the distributions of radioactivity in bands 1-3 of all bile and blood samples were similar to that of the injected material.
macytomas, where tetramer and hexamer accounted for 42-76% (by weight) of the plgA (10). Bile samples collected at 30, 60, 90, and 120 min had radioactive bands that coelectrophoresed with the three ~:5I-plgA bands present in the injected sample. No radiolabeled ligand was detected in bile before 15 min, consistent with the radioactivity measurements. Although the experimental results presented in Fig. 2 suggest that higher polymer forms of plgA were transported to bile faster than was the dimer, the experiment was repeated using a new plgA preparation, and no apparent rate differences were observed. Thus, it is not at present clear to what extent the various polymeric species produced by the mouse TEPC plasmacytoma are differentially transported from blood to bile. However, when rat bile from uninjected animals was analyzed by native PAGE and immunoblotfing (14) with an anti-alpha chain antibody, endogenous dimer, tetramer, and hexamers of IgA were all present, which indicates that the rat system can transport these polymers, whether endogenous or exogenous in origin.
~25I-plgA collected in bile samples up to 90 min, and the injected ~25I-plgA showed the same extent of binding and specific hapten elution from PC2rBSA-Sepharose 4B columns, which was 70-80% of that applied. This indicated that the intact J25I-plgA in bile was immunologically active after its transport across the hepatocyte and secretion. The immunoprecipitation of SC (using rabbit anti-SC) from bile samples collected 30-60 min after 125I-plgA injection indicated that at least 40% of the transported ~25I-plgA was bound to SC (data not shown). pIgA: More than 80% of the radioactivity in all plasma samples collected from 0-180 min was acid precipitable, and results of native PAGE revealed the presence of three ~25I-plgA bands that co-electrophoresed with those present in injected '25I-plgA samples (Fig. 2) . Since by these criteria the 12~I-pIgA remaining in the circulation at 120 rain was intact, it was puzzling why all of the molecules initially injected were not cleared. Comparable amounts (70-80%) of ligand from both injected and 120-rain plasma samples bound to and were specifically eluted from PC25-BSA-Sepharose columns, which indicates that antigen binding was retained in the uncleared pIgA. To examine the possibility that liver transport was progressively impaired during the experiment, a rat that had been injected 2 h earlier with a dose of t25I-pIgA was challenged with another dose of '2~I-pIgA at I0 times greater specific activity. The result was unequivocal. The second 125I-pIgA dose was transported into bile with kinetics identical to that of the first. Another possibility, that the t25I-pIgA remaining in the plasma at 120 rain could not be cleared, was addressed by a study of its behavior after administration to a second rat. Serum prepared from the blood of a rat that had been injected 2 h earlier with high specific activity 125I-pIgA was injected into a second rat. Calculated on the basis of the 125I-pIgA dose given to the first rat, only 4% more was cleared in the second animal, which indicates the near-complete inability of this 125I-pIgA to be transported into the bile. We concluded that either a population of ~25I-pIgA less active in transport was produced after injection into rats, or ~25I-plgA existed as a heterogeneous population of molecules before injection.
Assessment of 1251-plgA-HRP Conjugate
We next determined the clearance and transport characteristics of the HRP conjugate of 125I-plgA. The low endogenous HRP activity in bile allowed a direct comparison of the radioactivity and peroxidase activity transported to bile in our initial characterization of the conjugate. The kinetics of ~2~I-pIgA-HRP transport into bile measured both ways was similar to that of 12SI-plgA (Figs. 1 and 3) . Both radioactivity and peroxidase activity first appeared in bile at 20 rain and reached a maximum concentration at 60 min, within the 30-60-rain period in which bile ~2SI-plgA usually reached a maximum. However, more of the injected peroxidase activity (56%) than of the injected radioactivity (38%) was transported to bile (inset, Fig. 3 ). The t25I-pIgA-HRP radioactivity present in the liver (23% of injected) after the 120-rain experiment was somewhat higher than the 6-15 % range seen for the 180-min experiments. This probably reflects the greater percentage of injected t2~I-pIgA-HRP in transit through the hepatocyte at 120 min.
:>.100 Time (min) FtGUR[ 3 The transport of intravenously injected ~2Sl-plgA-HRP conjugate into the bile. 12Sl-plgA-HRP (300 #g p l~) was injected into the saphenous vein of a rat, and at various times the radioactivity (O) and peroxidase activity (0) in bile were determined. The inset shows the distribution of 92% of the radioactivity and a comparison of the radioactivity and peroxidase activity in the bile at 120 rain. Peroxidase activity of the conjugate could not be determined in liver and blood due to high endogenous activity.
We next characterized the injected and transported conjugates by native PAGE, the results of which are shown in Fig.  4 . The three bands observed with t25I-plgA alone were also present in the injected preparation of ~25I-plgA-HRP and contained both radiolabel and HRP activity. A comparison of the relative amounts of radioactivity and peroxidase activity in each band indicated that HRP was preferentially coupled to higher polymeric forms. There was also radioactivity at the top of the separating gel that had relatively less HRP activity (Fig. 4, A vs. B) . This radiolabeled material may represent species that have more than one plgA molecule bound per HRP molecule, with possible inactivation of HRP in such conjugates. When the '2SI-plgA-HRP transported to bile was analyzed on native gels, both radioactivity and HRP activity were detected in the three pleA bands that corresponded to the major plgA's injected (Fig. 4) . A discrete band containing HRP activity was also present above band 1, but its content of ~25I was not detectable above the background in that region of the gel (Fig. 4B) .
Finally, we found that >70% of both peroxidase activity and radioactivity transported to bile between 45 and 60 min after ~5I-plgA-HRP injection was bound and specifically eluted from PC25-BSA-Sepharose 4B. Thus, by several criteria, the HRP in bile was coupled to ~2~I-plgA, which indicates that the conjugate had crossed the hepatocyte intact.
Ultrastructural Examination of ~2Sl-plgA-HRP Transport Across the Hepatocyte
To characterize the transport of 1251-pIgA-HRP across the hepatocyte, the types and cellular distribution of structures that contained this electron microscopic tracer were determined at various times after in vivo administration of the conjugate. Fig. 5 illustrates qualitatively the types of 125I-pIgA-HRP-containing structures present in the sinusoidal, intermediate, and bile canalicular regions of hepatocytes 30 min after injection of the conjugate, when the distribution of labeled structures was approximately equal in these regions. Vesicles were the predominant labeled structures seen in every region of the cell at all times after injection. They accounted for -85% of all J25I-pIgA-HRP-structures, with tubules and multivesicular bodies composing the rest. However, the sizes of labeled vesicles found in the sinusoidal region (Fig. 5, a and b) tended to be smaller than those near the bile canaliculus (Fig. 5 d) . Our quantitation of these qualitative observations is presented below. pathway and kinetics of ligand transport, the cellular distribution of ~25I-pIgA-HRP structures was determined at various times after intravenous injection of conjugate. The results presented in Table I [25I-plgA-HRP STRUCTURES IN THE GOLGI-LYSO-SOME AREA: Previous work from this laboratory established that epidermal growth factor (6) and asialoglycoproteins Livers were fixed in situ at various times after administration of 12Sl-plgA-HRP (0.5-1.0 mg plgA) and mannan (1.0 rag) and then processed for peroxidase cytochemistry as described in Materials and Methods. Each discrete structure was scored as one, regardless of size and shape. Since three separate preparations of conjugate have been used in the above experiments, the conjugate(s) used for each administration time is indicated. The standard deviation was <10% for the combined data at 5 and 10 rain and in the intermediate region at 15 rain. However, the combined data for the sinusoidal and bile canalicular regions at 15 rain had standard deviations of 18 and 16%, respectively. The data for each region are presented as a percentage of total structures scored at a given time. Number of Vesicles The experiment was the same as that described in Table I . Examples of vesicles, tubules, and multivesicular bodies are shown in the micrographs of Fig. 5 . * Tubular structures -<700 nm long, * Circular structures -<295 nm in diameter. s Multivesicular bodies are vesicles >200 nm in diameter that contain distinguishable vesicles or other inclusions in their lumen. a No structures in Golgi-lysosomal region of cell.
(41), two ligands destined for lysosomal degradation, accumulated in endosomal structures within the Golgi-lysosome regions of hepatocytes before their entry into bona fide lysosomes. Therefore, we identified and quantified the 125I-plgA-HRP-containing structures in such regions to determine if a similar accumulation was occurring before secretion of plgA (Table II) Fig. 7, c-f ). Multivesicular bodies (MVB in Fig. 7 , a-e) were large, somewhat spherical structures >200 nm in diameter. These structures were occasionally seen in continuity with tubules (see Fig. 5 ), and in some cases vesicles appeared to be in continuity with tubules (e.g., see Fig. 7 , b and c).
DISCUSSION
The purpose of this study was to characterize the transcellular transport of plgA across the rat hepatocyte. Toward this goal, we biochemically characterized the transport of our ~25I-plgA (TEPC 15) and electron microscopic tracer (~25I-plgA-HRP).
Once satisfied that these molecules were being transported as expected, we undertook electron microscopic studies to characterize the plgA transport pathway.
Biochemical Characterization of ~2Sl-plgA and plgA-HRP Transport
Unlike asialoglycoproteins and asialo,agalactoglycoproteins, where >80% of the injected dose is cleared by the liver in l0 min (12) , ~25I-pIgA is cleared both less effectively and more slowly (40-55% in 180 min). The results indicate that mouse ~2SI-pIgA may exist as a mixture of transport-active and -inactive molecules before injection into animals. Perhaps SC-binding sites on some of the pIgA molecules are inactivated during the preparation of pIgA or its radioiodination. Alternatively, the transport-inactive molecules may lack their J chain and be unable to bind to their receptor, as Brandtzaeg and Prydz have suggested (2) . However, values in the literature for rat and human ~25I-pIgA uptake by the rat agree nicely with ours and are from 30 to 67% of injected L:SI-pIgA transported to bile in intact rats (17, 22, 25, 30, 40) , 27% in an isolated perfused liver (7) , and 53% in cultured hepatocytes (18) .
When we analyzed the specific electron microscopic tracer, ~25I-pIgA-HRP, we found that the transport kinetics of both radioactivity and peroxidase activity were similar (Fig. 3) ; however, relatively more peroxidase activity was transported to bile than was radioactivity. This difference may have been caused by the nature of the pIgA to which HRP was conjugated. HRP was reacted with a mixture ofpIgA that contained one part 12~I-pIgA and 100 parts unlabeled pIgA. Therefore, HRP was coupled mainly to unlabeled pIgA. The greater transport of HRP activity could therefore be accounted for by better binding of the unlabeled pIgA-HRP conjugate to SC than to the labeled pIgA and labeled conjugate. Thus, the pIgA-HRP conjugate is probably a better probe of pIgA transport than is the radioiodinated ligand. The substantial transport of both pIgA and peroxidase activity (Fig. 3) , together with our finding that m:SI-pIgA-HRP was transported into bile as an intact conjugate, indicated that the localization of HRP-containing structures accurately reflected the behavior of pIgA itself.
Electron Microscopic Study of ~2~I-plgA-HRP Transport
The distribution of ~25I-plgA-HRP-containing structures in the hepatocyte during the continuous uptake of conjugate indicated that after internalization at the sinusoidal front, J2~I-plgA-HRP rapidly appeared in both the intermediate and bile canalicular regions of cells (Table I) . ~25I-pIgA-HRP-containing structures could be detected in the latter region as early as 5 min after administration of the conjugate, and their percentage continued to increase up to 45 min. Within the intermediate and bile canalicular regions, many of the labeled structures could be localized to areas in which Golgi complexes and lysosomes were also present. HRP conjugates of asialoorosomucoid (41 ) and epidermal growth factor (6), two polypeptides destined for lysosomal degradation, appear in Golgi-lysosome areas of hepatocytes 4-5 min after their administration, the same time at which ~25I-pIgA-HRP structures appeared in these areas (Table II) . However, the types of structures that contain these conjugates were qualitatively different from those that contain pIgA-HRP. Although none of the three ligands was present in either bona fide stacks of Golgi complexes or in lysosomes, asialoorosomucoid and epidermal growth factors were present in a more complicated array of tubulovesicular structures than those seen for ~25I-pIgA-HRP, pIgA was found predominantly in vesicles. The different distributions of lysosome-vs. bile-destined ligands suggest either that these ligands enter the hepatocyte by internalization into different structures or that sorting of these ligands may begin soon after endocytosis and continue to near completion during transit of the molecules to Golgilysosomal areas. Alternatively, segregation may occur rapidly in the Golgi-lysosomal areas, with the resulting prelysosomal and presecretion compartments having relatively long residence times. Since HRP conjugates of asialoorosomucoid, epidermal growth factor, and pIgA occur in similar structures in the sinusoidal region of the hepatocyte, we believe they enter cells in the same vesicles and tubules. This would require a sorting of ligands within the cell. The dual ligand experiments of Courtoy et al. and of Geuze et al. support this hypothesis (5, 9) .
Several studies have suggested that pIgA is present only in vesicles during its transport across the hepatocyte (4, 2 l, 37), and another study has implicated smooth endoplasmic reticulum in addition to vesicles in ~25I-pIgA transport (27) . We saw no evidence for the involvement of smooth endoplasmic reticulum in serial sections of ~25I-pIgA-HRP-containing structures (Fig. 7) . However, 85% of the total ~25I-pIgA-HRPcontaining structures were vesicles. Nonetheless, we did find tubules and multivesicular bodies that contained conjugate (Fig. 5) . Since vesicles appeared much more often than did tubules or multivesicular bodies in juxtaposition to the bile canalicular plasma membrane, vesicles are probably the structures responsible for secretion of ~25I-pIgA into the bile. Furthermore, they were generally larger than ligand-containing vesicles near the sinusoidal front, implying transfer of ligand during its transport, fusion of vesicular carriers, or both. Similar types of large vesicles around bile canaliculi were reported by Renston et al. to contain unconjugated HRP, a fluid-phase pinocytic marker (28) . However, this tracer, which was administered at very high doses (10 mg/100 g body wt), was even more abundant in multivesicular bodies and secondary lysosomes of hepatocytes, which suggests that it nonselectively filled all those endocytic pathways that originate at the sinusoidal front (i.e., lysosomal, transcellular, and perhaps as yet unidentified routes). Our ~25I-pIgA-HRP conjugate exhibited must greater selectivity and at lower doses.
It is not currently clear why ~25I-pIgA-HRP was found in multivesicular bodies, structures commonly thought to be lysosomal precursors (6, 8, 41) . At this time, we cannot exclude the possibility that multivesicular bodies have a role in plgA transport. We believe a more likely explanation is that some ~25I-plgA-HRP molecules were directed to lysosomes because of simple missorting, or because of an alteration of injected conjugate that still allowed its specific uptake into hepatocytes but not its secretion into bile. The 125I-plgA-HRP-containing tubules we have describe6 may be analogous to the compartment of uncoupling of receptors and ligand described by Geuze et at., who used immunoelectron microscopy to detect endogenous plgA (9). The authors describe this compartment as an interconnected tubule network extending from the sinusoidal cell periphery to the trans-Golgi area, with the tubules participating most significantly in plgA sorting occurring at the sinusoidal-lateral cell corners of the hepatocyte. Our data showed the presence of ~25I-plgA-HRP-containing tubules in both sinusoidal and bile canalicular regions of the cell with no overwhelming preference for one location over the other. In addition, our serial section analysis of ~25I-plgA-HRP-containing structures strongly indicated no interconnections of tubules between the sinusoidal and bile canalicular regions (Fig. 7) . Thus, tubules probably do play a role in the transport of pIgA across the hepatocyte, since they are found throughout the hepatocyte, but they appear to be concentrated in the sinusoidal and bile canalicular regions. However, more work is required to resolve the apparent differences between our results and those of Geuze et al. (9) , since different morphologic methods were used in the two studies.
~25I-pIgA-HRP did not appear in the bile until 20 min, even though significant numbers of ligand-containing structures had accumulated in the bile canalicular region by 10 rain (Fig. 3 and Table I ). This observation suggested that there was a lag between 125I-pIgA vesicle accumulation in the bile canalicular region and fusion with the bile canalicular plasma membrane. The reason for such a lag is at present unclear but may involve the proteolytic cleavage of the membrane SC (Mr 120,000 in reducing SDS PAGE) to free SC, a step necessary for release of secretory IgA into the bile, since only free SC is detected in bile (34-36).
In conclusion, the quantitative biochemical and morphological approach we used to trace the pathway of pIgA across rat hepatocytes has significantly extended several recent morphological studies on pIgA transport (9, 37). We have shown that relatively simple tubules are involved in 125I-pIgA-HRP transport but that vesicles are the overwhelming intracellular structures containing pIgA. We feel that sorting of pIgA from lysosome-bound ligands either may begin soon after internalization and continue to completion during cellular transport, or may occur rapidly in the Golgi-lysosomal areas of the hepatocyte. The larger size of vesicles in the bile canalicular region of the hepatocyte relative to those in the sinusoidal region suggests that conjugate undergoes some change in "packaging" during its transport across the hepatocyte. Finally, our serial section analysis indicates that there are no extensive interconnections between structures in the sinusoidal and bile canalicular regions, leading us to conclude that pIgA is transported from blood to bile within membrane bound compartments, which themselves move across the hepatocyte, and not through a tubular complex, which connects sinusoidal and bile canalicular regions.
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